ArticleFrontiers in endocrinology2022

Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 Diabetes.

Giulia Di Dalmazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.